Роль инструментальных методов диагностики в оценке жизнеспособности миокарда у пациентов со сниженной контрактильностью левого желудочка
https://doi.org/10.51922/2616-633X.2023.7.2.2014
Аннотация
В данном обзоре описаны наиболее значимые инструментальные методы диагностики жизнеспособного миокарда у пациентов со сниженной контрактильностью левого желудочка, так как диагностика жизнеспособного миокарда играет важную роль в тактике лечения пациентов с ишемической дисфункцией миокарда.
Об авторах
С. В. Коваль
РНПЦ «Кардиология»
Беларусь
Беларусь
Минск
В. В. Шумовец
РНПЦ «Кардиология»
Беларусь
Беларусь
Минск
И. И. Гринчук
РНПЦ «Кардиология»
Беларусь
Беларусь
Минск
Т. В. Русак
РНПЦ «Кардиология»
Беларусь
Беларусь
Минск
А. А. Ефимова
РНПЦ «Кардиология».
Беларусь
Беларусь
Минск
Список литературы
1. Mozaffarian D., Benjamin E.J., Go A.S., Arnett D.K., Blaha M.J., Cushman M., de Ferranti S., Després J.P., Fullerton H.J. [et al.] Heart disease and stroke statistics- 2015 update: A report from the American Heart Association. Circulation, 2015, vol. 131, no. 4, pp. e29–322.
2. Ponikowski P., Voors A.A., Anker S.D., Bueno H., Cleland J.G.F., Coats A.J.S., Falk V., González-Juanatey J.R., Harjola V.P., Jankowska E.A. [et al.] 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J, 2016, vol. 37, no. 27, pp. 2129–2200.
3. Nikiforov V.S., Nikitin A.E., Tyrenko V.V., Svistov A.S. Ishemicheskaya disfunkciya miokarda [Ischemic myocardial dysfunction]. Мoscow, APKiPPRO, 2005, 102 p. (in Russian).
4. Gowda R.M., Khan I.A, Vasavada B.C., Sacchi T.J. Reversible myocardial dysfunction: basics and evaluation. Int J Cardiol, 2004, vol. 97, no. 3, pp. 349–353.
5. Soman P., Udelson J.E. Prognostic and therapeutic implications of myocardial viability in patients with heart failure. Curr Cardiol Rep, 2004, vol. 6, no. 3, pp. 211–216.
6. Yang T., Lu M.J., Sun H.S, Tang Y., Pan S.W., Zhao S.H. Myocardial scar identified by magnetic resonance imaging can predict left ventricular functional improvement after coronary artery bypass grafting. PLoS One, 2013, vol. 8, no. 12, pp. e81991.
7. Anagnostopoulos C., Georgakopoulos A., Pianou N., Nekolla S.G. Assessment of myocardial perfusion and viability by positron emission tomography. Int J Cardiol, 2013, vol. 16, no. 5, pp. 1737–1749.
8. Ghesani M., Depuey E.G., Rozanski A. Role of F-18 FDG Positron emission tomography (PET) in the assessment of myocardial viability. Echocardiography, 2005, vol. 22, no. 2, pp. 165–177.
9. Gropler R.J., Soto P. Recent advances in cardiac positron emission tomography in the clinical management of the cardiac patient. Curr Cardiol Rep, 2004, vol. 22, no. 1, pp. 20–26.
10. Mehta D., Iskandrian A.E. Myocardial viability: nuclear assessment. Echocardiography, 2005, vol. 22, no. 2, pp. 155–164.
11. Travin M.I., Bergmann S.R. Assessment of myocardial viability. Semin Nucl Med, 2005, vol. 35, no. 1, pp. 2–16.
12. Won K.S., Song B.I. Recent trends in nuclear cardiology practice. Chonnam Med J, 2013, vol. 49, no. 2, pp. 55–64.
13. Duncan B.H., Ahlberg A.W., Levine M.G., McGill C.C., Mann A., White M.P., Mather J.F., Waters D.D., Heller G.V. [et al.] Comparison of electrocardiographic-gated technetium-99m sestamibi singlephoton emission computed tomographic imaging and restredistribution thallium-201 in the prediction of myocardial viability. Am J Cardiol, 2000, vol. 85, no. 6, pp. 680–684.
14. Barrington S.F., Chambers J., Hallett W.A., O’Doherty M.J., Roxburgh J.C., Nunan T.O. Comparison of sestamibi, thallium, echocardiography and PET for the detection of hibernating myocardium. Eur J Nucl Med Mol Imaging, 2004, vol. 31, no. 3, pp. 355–361.
15. Senior R., Kaul S., Raval U., Lahiri A. Impact of revascularization and myocardial viability determined by nitrate-enhanced Tc-99m sestamibi and Tl-201 imaging on mortality and functional outcome in ischemic cardiomyopathy. J Nucl Cardiol, 2002, vol. 9, no. 5, pp. 454–462.
16. Yamagishi H., Akioka K., Hirata K., Sakanoue Y., Toda I., Yoshiyama M., Teragaki M., Takeuchi K., Yoshikawa J., Ochi H. Dobutamine stress electrocardiography-gated Tc-99m tetrofosmin SPECT for detection of viable but dysfunctional myocardium. J Nucl Cardiol, 2001, vol. 8, no. 1, pp. 58–67.
17. Verani M.S., Taillefer R., Iskandrian A.E., Mahmarian J.J., He Z.X., Orlandi C. 123I–IPPA SPECT for the prediction of enhanced left ventricular function after coronary bypass graft surgery. Multicenter IPPA Viability Trial Investigators. 123I-iodophenylpentadecanoic acid. J Nucl Med, 2000, vol. 41, no. 8, pp. 1299–1307.
18. Soukhov V.Y., Nikiforov V.S., Nikitin A.E., Kravchuk V.N., Shilov V., Hubulava G.G., Svistov A. Predictive value of myocardial perfusion and metabolism studies for prognosis of surgical revascularization efficacy. Eur J Nucl Med Mol Imaging, 2005, vol. 32, no. 1, pp. S56.
19. Tamaki N., Yoshinaga K. Novel iodinated tracers, MIBG and BMIPP, for nuclear cardiology. J Nucl Cardiol, 2011, vol. 18, no. 1, pp.135–143.
20. Fujita K., Kasama S., Kurabayashi M. Serial dual single-photon emission computed tomography of thallium-201 and iodine-123 beta-methyliodophenyl pentadecanoic acid scintigraphy can predict functional recovery of patients with coronary artery disease after coronary artery bypass graft surgery. Nucl Med Commun, 2015, vol. 36, no. 2, pp. 148–155.
21. Zaharova A.I., Nikiforov V.S., Svistov A.S. Diagnosticheskie vozmozhnosti ekhokardiografii u bol’nyh ishemicheskoj bolezn’yu serdca [Diagnostic possibilities of echocardiography in patients with ischemic heart disease]. Regional hemodynamics and microcirculation, 2007, vol. 6, no. 4, pp. 78–85. (in Russian).
22. Scognamiglio R., Negut C., Palisi M. Spontaneous recovery of myocardial asynergic segments following acute myocardial infarction. The role of post-extrasystolic potentiation echocardiography in the predischarge evaluation. Eur J Echocardiogr, 2003, vol. 4, no. 2, pp. 135–140.
23. Nikiforov V.S. Postekstrasistolicheskoe potencirovanie v diagnostike zhiznesposobnogo disfunkcioniruyushchego miokarda [Postextrasystolic potentiation in viable dysfunctioning myocardium diagnostics]. Ultrasound & Functional Diagnostics, 2008, no. 5, pp. 49–56. (in Russian).
24. Galatro K., Chaudhry F.A. Prognostic implications of myocardial contractile reserve in patients with ischemic cardiomyopathy. Echocardiography, 2000, vol. 17, no. 1, pp. 61–67.
25. Yao S.S., Chaudhry F.A. Assessment of myocardial viability with dobutamine stress echocardiography in patients with ischemic left ventricular dysfunction. Echocardiography, 2005, vol. 22, no. 1, pp. 71–83.
26. Bountioukos M., Schinkel A.F., Bax J.J., Biagini E., Rizzello V., Krenning B.J., Vourvouri E.C., Roelandt J.R., Poldermans D. Pulsed-wave tissue Doppler quantification of systolic and diastolic function of viable and nonviable myocardium in patients with ischemic cardiomyopathy. Am Heart J, 2004, vol. 148, no. 6, pp. 1079–1084.
27. Hoffmann R., Altiok E., Nowak B., Heussen N., Kühl H., Kaiser H.J., Büll U., Hanrath P. Strain rate measurement by doppler echocardiography allows improved assessment of myocardial viability inpatients with depressed left ventricular function. J Am Coll Cardiol, 2002, vol. 39, no. 3, pp. 443–449.
28. Nikiforov V.S., Nikitin A.E., Yalovets A.A. [et al.] Vyyavlenie zhiznesposobnogo miokarda u bol’nyh s postinfarktnym kardiosklerozom s pomoshch’yu dobutaminovoj stress-ekhokardiografii, dopolnennoj tkanevoj dopplerografiej [Detection of viable myocardium in patients with postinfarction cardiosclerosis using dobutamine stress echocardiography supplemented with tissue Doppler imaging]. Vestnik Rossiiskoi Voenno-medicinskoi academii, 2005, suppl. 2, pp. 97–99. (in Russian).
29. Gong L., Li D., Chen J., Wang X., Xu T., Li W., Ren S., Wang C. Assessment of myocardial viability in patients with acute myocardial infarction by two-dimensional speckle tracking echocardiography combined with lowdose dobutamine stress echocardiography. Int J Cardiovasc Imaging, 2013, vol. 29, no. 5, pp. 1017–1028.
30. Nikiforov V.S., Marsalskaya O.A., Novikov V.I. Ekhokardiograficheskaya ocenka deformacii miokarda v klinicheskoj praktike [Echocardiographic assessment of myocardial strain in clinical practice]. Saint Petersburg, KultInformPress, 2015. 28 р. (in Russian).
31. Hutyra M., Skala T., Kaminek M., Horak D., Kocher M., Tudos Z., Jarkovsky J., Precek J., Taborsky M. Speckle tracking echocardiography derived systolic longitudinal strain is better than rest single photon emission tomography perfusion imaging for nonviable myocardium identification. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub, 2013, vol. 157, no. 1, pp. 12–21.
32. Nikiforov V.S. Metody serdechno-sosudistoj vizualizacii v diagnostike zhiznesposobnogo miokarda pri ishemicheskoj bolezni serdca [Methods of cardiovascular visualization for diagnostic of viable myocardium in patients with ischemic heart disease]. Saint Petersburg, KultInformPress, 2012, 33 s. (in Russian).
33. Romero J., Xue X., Gonzalez W., Garcia M.J. CMR imaging assessing viability in patients with chronic ventricular dysfunction due to coronary artery disease: a meta- analysis of prospective trials. JACC Cardiovasc Imaging, 2012, vol. 5, no. 5, pp. 494–508.
34. Glaveckaite S., Valeviciene N., Palionis D., Puronaite R., Serpytis P., Laucevicius A. Prediction of long-term segmental and global functional recovery of hibernating myocardium after revascularisation based on low dose dobutamine and late gadolinium enhancement cardiovascular magnetic resonance. J Cardiovasc Magn Reson, 2014, vol. 16, pp. 83.
35. Gonzalez J.A., Kramer C.M. Role of imaging techniques for diagnosis, prognosis and management of heart failure patients: cardiac magnetic resonance. Curr Heart Fail Rep, 2015, vol. 12, no. 4, pp. 276–283.
36. Yang T., Lu M.J., Sun H.S., Tang Y., Pan S.W., Zhao S.H. Myocardial scar identified by magnetic resonance imaging can predict left ventricular functional improvement after coronary artery bypass grafting. PLoS One, 2013, vol. 8, no. 12, pp. e81991.
Рецензия
Для цитирования:
Коваль С.В., Шумовец В.В., Гринчук И.И., Русак Т.В., Ефимова А.А. Роль инструментальных методов диагностики в оценке жизнеспособности миокарда у пациентов со сниженной контрактильностью левого желудочка. Неотложная кардиология и кардиоваскулярные риски. 2023;7(2):2014-2020. https://doi.org/10.51922/2616-633X.2023.7.2.2014
For citation:
Koval S., Shumovets V., Grinchuk I., Rusak T., Yefimova A. The role of instrumental diagnostic methods in assessing myocardial viability in patients with reduced contractility of the left ventricle. Emergency Cardiology and Cardiovascular Risks journal. 2023;7(2):2014-2020. (In Russ.) https://doi.org/10.51922/2616-633X.2023.7.2.2014
Просмотров:
4
Послать статью по эл. почте 